C
Power Law company profile
COMPASS Pathways
Biotech & Life Sciences · London, United Kingdom · Founded 2016 · IPO 2020 Unicorn
Valuation
$1.02B
Market cap · Apr/2026
Global footprint
Where COMPASS Pathways has talent and traffic
AI talent share
1.2%
of workforce is AI talent
(3 of 248 staff)
(3 of 248 staff)
Core AI20.81%
Other AI10.4%
Non-AI workforce24598.79%
Web traffic by country
34K
monthly visits
across markets
across markets
🇺🇸 United States46.8%
🇬🇧 United Kingdom14.7%
🇨🇦 Canada8.8%
🇵🇭 Philippines7.4%
🇪🇸 Spain5.3%
Patent intelligence
$106M patent portfolio · 48 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$106M
10.4% of market cap · comparable to top peer Resilience ($108M)
48 active patent families
Where COMPASS Pathways innovates
PsilocybinPharmacologyMedicinal chemistryDiseaseAttention deficits
Above peer median on Market
Quality vs same-sector peers
COMPASS Pathways on the five Patsnap quality dimensions
COMPASS Pathways in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where COMPASS Pathways concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across COMPASS Pathways and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee COMPASS Pathways on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.